Pharmaceutical Executive-03-01-2011

Issue PDF
Pharmaceutical Executive

March 01, 2011

Castellani Takes Charge at PhRMA

Pharmaceutical Executive

Boehringer Ingelheim's PICASSO program helps it focus on engaging industry stakeholders to improve patient care

Pharmaceutical Executive

Despite its dimunitive size, the pharmaceutical industry looks to the Netherlands for a world-class medical infrastructure, new standards in innovation, and a closely-knit community of stakeholders

Pharmaceutical Executive

March 01, 2011

Ferring finds a new approach to communicate its value offering

Pharmaceutical Executive

March 01, 2011

Ipsen is redefining a standard for success in innovation with its local Dutch affiliate

Pharmaceutical Executive

With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence

Pharmaceutical Executive

A highlight of the Hay Group's annual study of Sales Force Effectiveness, focusing on managed care markets

Pharmaceutical Executive
Columns

March 01, 2011

When dealing with the pharmaceutical marketplace, why is keeping things simple so complex?

Pharmaceutical Executive
From the Editor

March 01, 2011

Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision

Pharmaceutical Executive
Features

March 01, 2011

Pharm Exec's annual feature applauding the people behind the best of pharma advertising over the past year

Pharmaceutical Executive

Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation

Pharmaceutical Executive

FDA's Sentinel Initiative raises broader questions about tapping patient information and health IT for comparative studies in drug development

Pharmaceutical Executive
Columns

March 01, 2011

The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process

Pharmaceutical Executive

A sneak preview of The Avoca Group's 2011 Annual Survey on CRO and Industry Relationships

Pharmaceutical Executive

Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.